SEC Tracker
Get the app
LMAT · XBRL financial data

Lemaitre Vascular financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (LMAT's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue from contracts with customers47,41148,883*53,47855,84954,81955,717*———year only——
Cost of goods and services sold16,59615,618*16,81317,38117,64117,127*18,45119,25815,09118,263*18,15519,618
Gross profit30,81533,26536,66538,46837,17838,590*41,42044,97445,955—48,39650,764
Research and development4,2244,351*4,0924,2843,6563,618*4,0953,5412,9703,533*4,0604,847
General and administrative7,7388,440*9,0138,8208,9339,492*10,48710,39610,75010,391*12,04611,110
Total operating expenses21,63523,059*24,79124,08824,03025,736*28,79428,83225,64327,358*30,62130,365
Operating income (loss)9,18010,20611,87414,38013,14812,854*12,62616,14220,31218,832*17,77520,399
Interest income835992*1,0011,1371,2011,610*2,9032,9803,8643,347*3,3243,386
Interest expense—year only000205*1,2901,2991,2971,298*1,3001,302
Other income (expense)—year only(78)(11)202(238)*2247(306)(581)*(127)(294)
Income tax expense (benefit)2,3242,848*2,9103,6803,4102,837*3,2304,2915,2114,718*3,9935,139
Net income (loss)7,5028,4659,88711,82611,14111,184*11,01113,77917,36215,582*15,67917,050
Earnings per share, basic USD per share0.340.380.440.530.500.50*0.490.610.770.69*0.690.75
Earnings per share, diluted USD per share0.330.380.440.520.490.49*0.480.600.750.72*0.680.74
Weighted average shares, basic thousands of shares22,26322,279*22,36522,45822,47622,508*22,57022,61422,66022,706*22,80122,858
Weighted average shares, diluted thousands of shares22,48122,483*22,57022,72522,83622,982*22,89922,89224,39221,532*23,03124,531

Balance sheet

CSV

Fiscal quarters (LMAT's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents18,05124,26926,59522,26821,00125,61025,34027,17725,49428,24426,85126,625
Marketable securities78,96780,80581,69390,831102,888274,112277,209292,311317,561330,876340,382349,615
Accounts receivable23,88225,06430,23630,82232,26930,06335,11236,53732,41633,61035,77035,682
Prepaid and other current assets5,0976,3803,8635,2175,9377,4804,5465,7165,7615,0803,9985,872
Total current assets182,184194,598202,962212,811227,116402,192408,113430,126452,025468,232477,821488,297
Property and equipment, net21,35721,75422,17423,11723,92424,80025,10625,35726,46426,99728,54329,591
Right-of-use asset15,85018,02717,79517,29417,19516,76816,23316,51516,04015,76219,83219,998
Goodwill65,94565,94565,94565,94565,94565,94565,94565,94565,94565,94565,94565,945
Total assets334,012346,778353,957363,079377,025551,817556,006577,591598,069615,690629,526640,549
Accounts payable4,3713,7343,0891,9951,6511,7612,1814,9143,4653,6464,1803,236
Accrued liabilities21,78823,65021,11820,78523,49324,73219,92922,97826,93329,41125,26822,880
Total current liabilities29,02929,87926,81025,44629,34330,60724,74530,81633,28736,32333,36929,935
Lease liability, non-current14,13216,62416,35415,81815,60315,23214,74214,85514,41414,00317,50217,724
Total liabilities45,37548,87845,45443,54745,951214,527208,434214,905219,146222,174222,904220,207
Retained earnings110,081115,430121,728129,961137,506145,090151,584160,843173,670184,715194,683206,017
Total stockholders' equity288,637297,900308,503319,532331,074337,290347,572362,686378,923393,516406,622420,342
Total liabilities and equity334,012346,778353,957363,079377,025551,817556,006577,591598,069615,690629,526640,549
Common shares outstanding (cover page) thousands of shares22,26322,33722,44622,46922,48422,55922,59422,63822,68622,77822,85122,869

Cash flows

CSV

Fiscal quarters (LMAT's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)7,5028,4659,88711,82611,14111,184*11,01113,77917,36215,582*15,67917,050
Stock-based compensation1,3131,404*1,6101,6091,6101,739*2,0461,9441,7402,096*2,0921,935
Depreciation and amortization2,395*2,443*2,3822,384*2,426*2,478*2,5522,648*2,613*2,605*2,6232,662*
Net cash from operating activities11,823*10,746*5,0719,625*14,246*15,182*9,03920,291*28,764*23,157*15,09315,965*
Net cash from investing activities(9,851)*(2,261)*(2,361)(11,003)*(12,864)*(173,892)*(4,320)(16,349)*(27,447)*(16,825)*(13,121)(11,078)*
Proceeds from issuing common stock0*1,097*———year only——————
Share repurchases5*667*3587*1*1,353*6014*0*1,216*46017*
Dividends paid3,117*3,116*3,5893,593*3,596*3,600*4,5174,520*4,535*4,537*5,7115,716*
Net cash from financing activities(3,122)*(2,686)*39(2,870)*(3,148)*164,081*(5,239)(2,764)*(2,950)*(3,587)*(3,219)(5,052)*
Net change in cash(1,437)*6,218*2,326(4,327)*(1,267)*4,609*(270)1,837*(1,683)*2,750*(1,393)(226)*

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Lemaitre Vascular26,625not reported15,965*22.9M— 10-QJun 30, 2026
Ufp Technologies9,045173,96415,612*7.7M— 10-QJun 30, 2026
AtriCure167,786153,60422,192*50.9M— 10-QJun 30, 2026
Heartflow34,36264,082(8,577)*87.0M19.0 quarters 10-QJun 30, 2026
Enovis12,563582,78275,032*57.7M— 10-QJul 3, 2026
Artivion77,316125,757(1,266)*48.8M61.1 quarters 10-QJun 30, 2026
Alphatec Holdings79,936221,17218,856*155.1M— 10-QSep 30, 2026
Tandem Diabetes Care62,818254,560(34,630)*69.6M13.2 quarters 10-QJun 30, 2026
Haemonetics223,384339,38052,32345.5M— 10-QJun 27, 2026

Not investment advice. Not affiliated with the U.S. SEC.